Page last updated: 2024-08-23

paclitaxel and Neuroectodermal Tumors, Primitive

paclitaxel has been researched along with Neuroectodermal Tumors, Primitive in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ali-Fehmi, R; Bryant, CS; Jelsema, J; Malone, JM; Shah, JP	1
Ainsworth, S; Helson, C; Helson, L; Malik, S; Mangiardi, J	1
Ardouin, P; Bénard, J; Bissery, MC; Boland, I; Bressac-de-Paillerets, B; Gouyette, A; Gyergyay, F; Morizet, J; Terrier-Lacombe, MJ; Vassal, G; Vénuat, AM	1

Reviews

1 review(s) available for paclitaxel and Neuroectodermal Tumors, Primitive

Article	Year
Carboplatin and paclitaxel adjuvant chemotherapy in primitive neuroectodermal tumor of the uterine corpus. American journal of obstetrics and gynecology, 2009, Volume: 200, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Middle Aged; Neuroectodermal Tumors, Primitive; Paclitaxel; Postmenopause; Radiotherapy, Adjuvant; Uterine Hemorrhage; Uterine Neoplasms	2009

Article

Year

Carboplatin and paclitaxel adjuvant chemotherapy in primitive neuroectodermal tumor of the uterine corpus.

American journal of obstetrics and gynecology, 2009, Volume: 200, Issue:2

Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Middle Aged; Neuroectodermal Tumors, Primitive; Paclitaxel; Postmenopause; Radiotherapy, Adjuvant; Uterine Hemorrhage; Uterine Neoplasms

2009

Other Studies

2 other study(ies) available for paclitaxel and Neuroectodermal Tumors, Primitive

Article	Year
A saturation threshold for taxol cytotoxicity in human glial and neuroblastoma cells. Anti-cancer drugs, 1993, Volume: 4, Issue:4 Topics: Brain Neoplasms; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Kinetics; Neuroblastoma; Neuroectodermal Tumors, Primitive; Paclitaxel; Tumor Cells, Cultured	1993
Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts. British journal of cancer, 1996, Volume: 74, Issue:4 Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line; Cisplatin; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; Female; Humans; Irinotecan; Mice; Mice, Nude; Neuroblastoma; Neuroectodermal Tumors, Primitive; Neuroectodermal Tumors, Primitive, Peripheral; Paclitaxel; Thiotepa; Topoisomerase I Inhibitors; Transplantation, Heterologous	1996

Article

Year

A saturation threshold for taxol cytotoxicity in human glial and neuroblastoma cells.

Anti-cancer drugs, 1993, Volume: 4, Issue:4

Topics: Brain Neoplasms; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Kinetics; Neuroblastoma; Neuroectodermal Tumors, Primitive; Paclitaxel; Tumor Cells, Cultured

1993

Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts.

British journal of cancer, 1996, Volume: 74, Issue:4

Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line; Cisplatin; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; Female; Humans; Irinotecan; Mice; Mice, Nude; Neuroblastoma; Neuroectodermal Tumors, Primitive; Neuroectodermal Tumors, Primitive, Peripheral; Paclitaxel; Thiotepa; Topoisomerase I Inhibitors; Transplantation, Heterologous

1996